Five notes:
1. Net sales of $198.6 million represent a 6% year-over-year increase, according to a news release.
2. U.S. spine fixation sales grew 12% year-over-year, and this was largely driven by distribution expansion and growing in existing markets.
3. Bone growth therapies sales also grew 12% year-over-year. This is the sixth consecutive quarter with double-digit sales increases for the segment.
4. The company’s net loss grew year-over-year in the second quarter. The company saw a $33.4 million net loss in the second quarter compared to $26.7 million in the same time last year.
5. Orthofix increased its 2024 net sales guidance and estimates full-year sales to be $795 million to $800 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
